Have any questions?

ZGL Cancer Panel

Where Every Strand of DNA Leads to a Brighter Future

Overview

 Zarqa’s cancer gene panel is a highly specific and sensitive genetic test designed to detect mutations in genes associated with an increased risk of developing various cancers. The panel includes all known highly penetrant cancer genes, selected based on their potential to significantly impact the development of specific cancers.

Key Features:

Extensive Gene Coverage

Zarqa’s cancer gene panel includes 66 genes known to be linked with a high risk of cancer.

Cancer Types

The panel targets genes associated with breast, ovarian, colorectal, gastric, bowel, endometrial, pancreatic, melanoma, renal, and prostate cancers.

High Sensitivity and Specificity

Ensures accurate detection of genetic mutations.

Gene List

ABRAXAS1, APC, ATM, AXIN2, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, CDKN2A, CHEK2, DICER1, DIS3L2, EPCAM, FANCC, FH, FLCN, GALNT12, HNF1B, HOXB13, KIT, MC1R, MEN1, MET, MITF, MLH1, MLH3, MRE11, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NTHL1, PALB2, PMS1, PMS2, POLD1, POLE, POT1, PRSS1, PTCH1, PTEN, RAD50, RAD51C, RAD51D, RECQL, RET, RNF43, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, SMARCA4, STK11, TGFBR2, TP53, TSC1, TSC2, VHL, WT1, XRCC2, XRCC3

Diseases Covered

Breast Cancer

Ovarian Cancer

Colorectal Cancer

Gastric Cancer

Bowel Cancer

Endometrial Cancer

Pancreatic Cancer

Melanoma

Renal Cancer

Prostate Cancer

Benefits

Early Detection: Helps in the early identification of genetic predispositions to cancer.

Personalized Medicine: Enables personalized treatment plans based on genetic makeup.

Comprehensive Screening: Covers a broad range of cancers, providing extensive genetic insights.